Avanos Medical, Inc. (AVNS)
USD 16.18
(-4.94%)
USD 16.18
(-4.94%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 673.3 Million | 820 Million | 744.6 Million | 714.8 Million | 697.6 Million | 652.3 Million |
| Cost of Revenue | 293.6 Million | 370 Million | 380.3 Million | 341.5 Million | 295.4 Million | 261.4 Million |
| Gross Profit | 379.7 Million | 450 Million | 364.3 Million | 373.3 Million | 402.2 Million | 390.9 Million |
| Operating Expenses | 375.5 Million | 376 Million | 355.4 Million | 419.4 Million | 457.9 Million | 390.4 Million |
| Selling, General and Administrative Expenses | 318.1 Million | 341.9 Million | 300.3 Million | 332.6 Million | 399.1 Million | 340.4 Million |
| Research and Development Expenses | 27.2 Million | 30.6 Million | 32.3 Million | 34.9 Million | 37.7 Million | 41.8 Million |
| Other Expenses | - | 3.5 Million | 22.8 Million | 51.9 Million | 21.1 Million | 8.2 Million |
| Cost and Expenses | 669.1 Million | 746 Million | 735.7 Million | 760.9 Million | 753.3 Million | 651.8 Million |
| Operating Income | 4.2 Million | 74 Million | 8.9 Million | -46.1 Million | -55.7 Million | 500 Thousand |
| Interest Expense | 15 Million | 10 Million | 3.3 Million | 15.6 Million | 15 Million | 26.4 Million |
| Income Tax Expense | 2 Million | 14.7 Million | 600 Thousand | -33.3 Million | -18.1 Million | -9.6 Million |
| Earnings before Tax | -7.9 Million | 65.2 Million | 5.8 Million | -60.5 Million | -64 Million | -18.1 Million |
| Net Income | -61.8 Million | 50.5 Million | 6.3 Million | -27.2 Million | -45.9 Million | 57.5 Million |
| Earnings Per Share Basic | -1.33 | 1.08 | 0.13 | -0.57 | -0.96 | 1.22 |
| Earnings Per Share Diluted | -1.33 | 1.07 | 0.13 | -0.57 | -0.96 | 1.22 |
| Weighted Average Shares Outstanding | 46.6 Million | 46.9 Million | 48.1 Million | 47.8 Million | 47.6 Million | 47.2 Million |
| Weighted Average Shares Outstanding (Diluted) | 46.6 Million | 47.3 Million | 48.6 Million | 47.8 Million | 47.6 Million | 47.2 Million |
| Gross Margin | 0.56 | 0.55 | 0.49 | 0.52 | 0.58 | 0.60 |
| EBIT Margin | 0.08 | 0.15 | 0.06 | -0.00 | -0.02 | 0.06 |
| Profit Margin | -0.09 | 0.06 | 0.01 | -0.04 | -0.07 | 0.09 |
| EBITDA | 53.2 Million | 77.8 Million | 8.9 Million | -2 Million | -12.1 Million | 65.7 Million |
| Earnings Before Tax Margin | 0.01 | 0.09 | 0.01 | -0.06 | -0.08 | 0.00 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 170.4 Million | 171.7 Million | 166.1 Million | 673.3 Million | 173.3 Million | 171.3 Million |
| Cost of Revenue | 77.5 Million | 76.1 Million | 71.3 Million | 290.6 Million | 75.9 Million | 75.8 Million |
| Gross Profit | 92.9 Million | 95.6 Million | 94.8 Million | 382.7 Million | 97.4 Million | 95.5 Million |
| Operating Expenses | 80.9 Million | 79.5 Million | 87.4 Million | 330.3 Million | 75.2 Million | 94.3 Million |
| Selling, General and Administrative Expenses | 74.3 Million | 73.2 Million | 80.4 Million | - | 68.4 Million | 78.7 Million |
| Research and Development Expenses | 7.2 Million | 6.3 Million | 7 Million | - | 6.8 Million | 6.1 Million |
| Other Expenses | -600 Thousand | 7.5 Million | - | - | -1.3 Million | - |
| Cost and Expenses | 158.4 Million | 155.6 Million | 158.7 Million | 620.9 Million | 151.1 Million | 170.1 Million |
| Operating Income | 12 Million | 16.1 Million | 7.4 Million | 52.4 Million | 22.2 Million | 1.2 Million |
| Interest Expense | 3.2 Million | 3.1 Million | 3.1 Million | 15 Million | 3.3 Million | 4.7 Million |
| Income Tax Expense | 3.6 Million | 1.9 Million | 1 Million | 2 Million | -2.1 Million | 6.2 Million |
| Earnings before Tax | 9.5 Million | 6.2 Million | 1.5 Million | -7.9 Million | 8.9 Million | -2.6 Million |
| Net Income | 4.3 Million | 1.8 Million | -900 Thousand | -61.8 Million | 10.5 Million | -3.7 Million |
| Earnings Per Share Basic | 0.10 | 0.04 | -0.02 | - | 0.23 | -0.08 |
| Earnings Per Share Diluted | 0.09 | 0.04 | -0.02 | - | 0.23 | -0.08 |
| Weighted Average Shares Outstanding | 46 Million | 45.9 Million | 46.2 Million | 46.6 Million | 46.2 Million | 46.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 46.6 Million | 46.3 Million | 46.2 Million | 46.6 Million | 46.6 Million | 46.8 Million |
| Gross Margin | 0.55 | 0.56 | 0.57 | 0.57 | 0.56 | 0.56 |
| EBIT Margin | 0.14 | 0.16 | 0.11 | - | 0.19 | 0.08 |
| Profit Margin | 0.03 | 0.01 | -0.01 | -0.09 | 0.06 | -0.02 |
| EBITDA | 24.4 Million | 27.4 Million | 18.8 Million | - | 33.7 Million | 13.1 Million |
| Earnings Before Tax Margin | 0.07 | 0.09 | 0.04 | 0.08 | 0.13 | 0.01 |
4838
VVPR
000889
MBR
1793
301005